Citius Pharmaceuticals Inc. (CTXR): Investors are paying attention to this stock – Invest Chronicle

Citius Pharmaceuticals Inc. (CTXR): Investors are paying attention to this stock

At the end of the latest market close, Citius Pharmaceuticals Inc. (CTXR) was valued at $1.54. In that particular session, Stock kicked-off at the price of $1.59 while reaching the peak value of $1.59 and lowest value recorded on the day was $1.53. The stock current value is $1.52.Recently in News on January 4, 2022, Citius Pharmaceuticals, Inc. to Present at Upcoming Virtual Conferences. H.C. Wainwright BioConnect 2022 Conference January 10-13, 2022. You can read further details here

Citius Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.7300 on 01/04/22, with the lowest value was $1.5100 for the same time period, recorded on 01/13/22.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Citius Pharmaceuticals Inc. (CTXR) full year performance was 40.00%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Citius Pharmaceuticals Inc. shares are logging -66.56% during the 52-week period from high price, and 42.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.07 and $4.56.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 874962 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Citius Pharmaceuticals Inc. (CTXR) recorded performance in the market was 0.00%, having the revenues showcasing -24.51% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 224.90M, as it employees total of 15 workers.

Market experts do have their say about Citius Pharmaceuticals Inc. (CTXR)

During the last month, 0 analysts gave the Citius Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.8695, with a change in the price was noted -0.39. In a similar fashion, Citius Pharmaceuticals Inc. posted a movement of -20.64% for the period of last 100 days, recording 2,154,203 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CTXR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

>> 7 Top Picks for the Post-Pandemic Economy << 

Technical breakdown of Citius Pharmaceuticals Inc. (CTXR)

Raw Stochastic average of Citius Pharmaceuticals Inc. in the period of last 50 days is set at 3.02%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.59%. In the last 20 days, the company’s Stochastic %K was 16.02% and its Stochastic %D was recorded 22.81%.

Bearing in mind the latest performance of Citius Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording 0.00%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -19.79%, alongside a boost of 40.00% for the period of the last 12 months. The shares increased approximately by -3.14% in the 7-day charts and went up by -10.98% in the period of the last 30 days. Common stock shares were lifted by -24.51% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts